Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)

Tibet Weixinkang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	92.43	212.22	216.44	269.43	519.32	243.77
Trading Asset Securities	920.26	770	803	625.32	287	467.78
Cash & Short-Term Investments	1,013	982.22	1,019	894.75	806.32	711.55
Cash Growth	-0.48%	-3.65%	13.94%	10.97%	13.32%	23.64%
Accounts Receivable	177.77	134.87	172.29	179.77	222.85	193.13
Other Receivables	2.42	2.17	1.93	2.2	2.14	1.22
Receivables	180.19	137.04	174.22	181.96	224.99	194.35
Inventory	59.84	59.82	41.96	38.34	32.54	22.68
Prepaid Expenses	-	0.07	2.62	1.73	1.68	2.14
Other Current Assets	112.37	109.77	77.14	83.12	73.43	78.44
Total Current Assets	1,365	1,289	1,315	1,200	1,139	1,009
Property, Plant & Equipment	410.22	416.46	380.25	361.21	333.73	324.14
Long-Term Investments	77.1	74.95	69.05	75.88	71.33	62.49
Other Intangible Assets	19.37	23.29	16.59	35.39	24.4	12.83
Long-Term Deferred Tax Assets	24.7	28.88	42.92	56.21	30.18	9.75
Long-Term Deferred Charges	48.84	15.73	16.91	26.36	41.52	73.35
Other Long-Term Assets	11.08	18.63	12.59	21.93	25.29	3.85
Total Assets	1,956	1,867	1,854	1,777	1,665	1,496

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	241.61	9.31	5.48	1.47	3.5	0.85
Accrued Expenses	10.37	255.69	314.28	269.95	284.17	271.98
Current Portion of Leases	-	3.97	2.89	3.86	2.31	2.47
Current Income Taxes Payable	18.49	2.06	0.66	3.83	6.78	4.3
Current Unearned Revenue	1.78	6.39	7.24	4.4	6.54	7.75
Other Current Liabilities	66.17	70.89	96.63	111.27	108.5	131.92
Total Current Liabilities	344.8	348.31	427.18	394.79	411.8	419.26
Long-Term Leases	3.08	7.23	2.38	3.82	3.48	2.35
Long-Term Unearned Revenue	4.94	4.17	7.05	3.84	5.25	6.7
Pension & Post-Retirement Benefits	-	20.27	28.86	-	-	-
Long-Term Deferred Tax Liabilities	9.01	10.5	2.78	3.46	1.17	-
Other Long-Term Liabilities	20.32	-	-	30.64	23.14	-
Total Liabilities	382.14	390.49	468.24	436.55	444.84	428.31

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	435.16	435.16	435.16	435.16	435.16	435.92
Additional Paid-In Capital	347.64	347.64	347.64	347.15	341.35	318.64
Retained Earnings	821.49	722.76	631.28	579.63	453.82	346.51
Treasury Stock	-30	-30	-30	-22.37	-23.8	-52.88
Comprehensive Income & Other	-0.05	0.8	1.36	0.78	14.05	19.07
Total Common Equity	1,574	1,476	1,385	1,340	1,221	1,067
Shareholders' Equity	1,574	1,476	1,385	1,340	1,221	1,067
Total Liabilities & Equity	1,956	1,867	1,854	1,777	1,665	1,496

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	9.45	11.2	5.27	7.68	5.79	4.81
Net Cash (Debt)	1,003	971.02	1,014	887.07	800.53	706.73
Net Cash Growth	-0.54%	-4.25%	14.33%	10.81%	13.27%	22.80%
Net Cash Per Share	2.32	2.25	2.35	2.07	1.85	1.69
Filing Date Shares Outstanding	425.61	432.33	432.33	435.16	435.16	435.92
Total Common Shares Outstanding	425.61	432.33	432.33	435.16	435.16	435.92
Working Capital	1,020	940.6	888.19	805.12	727.17	589.9
Book Value Per Share	3.70	3.41	3.20	3.08	2.80	2.45
Tangible Book Value	1,555	1,453	1,369	1,305	1,196	1,054
Tangible Book Value Per Share	3.65	3.36	3.17	3.00	2.75	2.42
Buildings	-	328.89	285.16	280.15	260.92	258.81
Machinery	-	339.93	297.15	274.57	236.19	215.29
Construction In Progress	-	21.45	37.98	15.19	17.11	-

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error